UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 911

Sortiert nach

Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy

Journal of the American Heart Association, 2020-09, Vol.9 (17), p.e016948-e016948

2020

Volltextzugriff (PDF)

Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes

Nature communications, 2022-04, Vol.13 (1), p.2318-2318, Article 2318

2022

Volltextzugriff (PDF)

Cardiovascular risk and dyslipidemia among persons living with HIV: a review

BMC infectious diseases, 2017-08, Vol.17 (1), p.551-551, Article 551

2017

Volltextzugriff (PDF)

Implications of AB0 blood group in hypertensive patients with covid-19

BMC cardiovascular disorders, 2020-08, Vol.20 (1), p.373-373, Article 373

2020

Volltextzugriff (PDF)

Cardiovascular disease risk in liver transplant recipients transplanted due to chronic viral hepatitis

PloS one, 2022-03, Vol.17 (3), p.e0265178-e0265178

2022

Volltextzugriff (PDF)

Clinical and neuropsychological features of violence in schizophrenia: A prospective cohort study

Schizophrenia research, 2017-03, Vol.181, p.124-130

2017

Volltextzugriff (PDF)

BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients

Genes, 2022-07, Vol.13 (7), p.1290

2022

Volltextzugriff (PDF)

Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study

Viruses, 2024-05, Vol.16 (5), p.777

2024

Volltextzugriff (PDF)

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)

BMC infectious diseases, 2018-07, Vol.18 (1), p.357-357, Article 357

2018

Volltextzugriff (PDF)

Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens

BMC infectious diseases, 2023-04, Vol.23 (1), p.227-227, Article 227

2023

Volltextzugriff (PDF)

Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19

Scientific reports, 2022-04, Vol.12 (1), p.5771-5771, Article 5771

2022

Volltextzugriff (PDF)

Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study

BMC public health, 2020-05, Vol.20 (1), p.734-734, Article 734

2020

Volltextzugriff (PDF)

Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study

Frontiers in aging neuroscience, 2021-06, Vol.13, p.698184-698184

2021

Volltextzugriff (PDF)

Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study

BMC infectious diseases, 2019-06, Vol.19 (1), p.555-555, Article 555

2019

Volltextzugriff (PDF)

Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?

BMC infectious diseases, 2022-09, Vol.22 (1), p.1-745, Article 745

2022

Volltextzugriff (PDF)

The metabolic syndrome and HIV infection

Current pharmaceutical design, 2014-01, Vol.20 (31), p.4975

2014

Volltextzugriff (PDF)

The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile

Drug design, development and therapy, 2020-01, Vol.14, p.5515-5520

2020

Volltextzugriff (PDF)

Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study

Journal of infection and public health, 2023-09, Vol.16 (9), p.1485-1491

2023

Volltextzugriff (PDF)

Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens

Pathogens (Basel), 2023-07, Vol.12 (7), p.925

2023

Volltextzugriff (PDF)

Profile of Co-Infection Prevalence and Antibiotics Use among COVID-19 Patients

Pathogens (Basel), 2022-10, Vol.11 (11), p.1250

2022

Volltextzugriff (PDF)

Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project

Journal of infection and public health, 2022-05, Vol.15 (5), p.562-565

2022

Volltextzugriff (PDF)

1 – 25 von 911

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(833)
Mit Volltextzugriff
(817)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(688)
Life Sciences & Biomedicine
(624)
Humans
(362)
Male
(361)
Animals
(244)
Female
(227)
Biological And Medical Sciences
(183)
Pharmacology & Pharmacy
(158)
Middle Aged
(152)
Adult
(131)
Aged
(107)
Medical Sciences
(107)
In Vitro Techniques
(100)
Rats
(98)
Infectious Diseases
(92)
Muscle Contraction - Drug Effects
(83)
Fundamental And Applied Biological Sciences. Psychology
(82)
Capsaicin - Pharmacology
(71)
Endocrinology & Metabolism
(70)
Guinea Pigs
(68)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy

Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes

Cardiovascular risk and dyslipidemia among persons living with HIV: a review

Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study

Implications of AB0 blood group in hypertensive patients with covid-19

Cardiovascular disease risk in liver transplant recipients transplanted due to chronic viral hepatitis

Clinical and neuropsychological features of violence in schizophrenia: A prospective cohort study

BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients

Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)

Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens

Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19

Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project

Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study

Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study

Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?

The metabolic syndrome and HIV infection

The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile

Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study

Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting

Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study

Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens

Profile of Co-Infection Prevalence and Antibiotics Use among COVID-19 Patients

Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project

Suchergebnisse filtern